CSIMarket
 
Medtronic Plc  (MDT)
Other Ticker:  
 
 

Medtronic Plc's Customers Performance

MDT

 
MDT's Source of Revenues Medtronic Plc's Corporate Customers have recorded an advance in their cost of revenue by 8.92 % in the 4 quarter 2023 year on year, sequentially costs of revenue grew by 33.76 %. During the corresponding time, Medtronic Plc recorded revenue increase by 4.68 % year on year, sequentially revenue grew by 1.32 %. While revenue at the Medtronic Plc's corporate clients recorded rose by 9.16 % year on year, sequentially revenue grew by 26.07 %.

List of MDT Customers




Medtronic Plc's Customers have recorded an advance in their cost of revenue by 8.92 % in the 4 quarter 2023 year on year, sequentially costs of revenue grew by 33.76 %, for the same period Medtronic Plc recorded revenue increase by 4.68 % year on year, sequentially revenue grew by 1.32 %.

List of MDT Customers


   
Customers Net Income fell in Q4 by Customers Net margin fell to %
-1.34 % 2.96 %



Medtronic Plc's Customers, Q4 2023 Revenue Growth By Industry
Customers in Healthcare Facilities Industry      2.3 %
Customers in Medical Laboratories Industry -1.93 %   
Customers in Electronic Instruments & Controls Industry      12.6 %
Customers in Pharmacy Services & Retail Drugstore Industry      11.89 %
     
• Customers Valuation • Customers Mgmt. Effect.


Medtronic Plc's Comment on Sales, Marketing and Customers



We sell most of our medical devices through direct sales representatives in the U.S. and a combination of direct sales representatives and independent distributors in markets outside the U.S. The three largest markets for our medical devices are the U.S., Western Europe, and Japan. Emerging markets are an area of increasing focus and opportunity as we believe they remain underpenetrated.

Our marketing and sales strategy is focused on rapid, cost-effective delivery of high-quality products to a diverse group of customers worldwide - including physicians, hospitals, other medical institutions, and group purchasing organizations. To achieve this objective, we organize our marketing and sales teams around physician specialties. This focus enables us to develop highly knowledgeable and dedicated sales representatives who are able to foster strong relationships with physicians and other customers and enhance our ability to cross-sell complementary products. We believe that we maintain excellent working relationships with physicians and others in the medical industry that enable us to gain a detailed understanding of therapeutic and diagnostic developments, trends, and emerging opportunities and respond quickly to the changing needs of physicians and patients. We attempt to enhance our presence in the medical community through active participation in medical meetings and by conducting comprehensive training and educational activities. We believe that these activities contribute to physician expertise.

In keeping with the increased emphasis on cost-effectiveness in health care delivery, the current trend among hospitals and other customers of medical device manufacturers is to consolidate into larger purchasing groups to enhance purchasing power. As a result, transactions with customers have become increasingly significant and more complex. This enhanced purchasing power may also lead to pressure on pricing and increased use of preferred vendors. Our customer base continues to evolve to reflect such economic changes across the geographic markets we serve. We are not dependent on any single customer for more than 10 percent of our total net sales.



  News about Medtronic Plc Contracts

Medtronic Unveils Cutting-Edge Percept RC Neurostimulator with BrainSense Technology, Revolutionizing Deep Brain Stimulation

FDA Approves Medtronic's Advanced Percept RC Neurostimulator with Exclusive BrainSense Technology: Revolutionizing Deep Brain StimulationIn a breakthrough development, the FDA has granted approval to Medtronic for its latest innovation - the Percept RC neurostimulator. Esteemed as the first and only deep brain stimulation system with sensing, directionality, and advanced programming, the Percept RC is set to revolutionize the treatment of neurological disorders. Medtronic plc, a global leader in healthcare technology, unveiled this revolutionary device on January 8, 2024.The Percept RC neurostimulator, equipped with exclusive BrainSense technology, marks a significant leap forward in the field of deep brain ...




Medtronic Plc's Comment on Sales, Marketing and Customers


We sell most of our medical devices through direct sales representatives in the U.S. and a combination of direct sales representatives and independent distributors in markets outside the U.S. The three largest markets for our medical devices are the U.S., Western Europe, and Japan. Emerging markets are an area of increasing focus and opportunity as we believe they remain underpenetrated.

Our marketing and sales strategy is focused on rapid, cost-effective delivery of high-quality products to a diverse group of customers worldwide - including physicians, hospitals, other medical institutions, and group purchasing organizations. To achieve this objective, we organize our marketing and sales teams around physician specialties. This focus enables us to develop highly knowledgeable and dedicated sales representatives who are able to foster strong relationships with physicians and other customers and enhance our ability to cross-sell complementary products. We believe that we maintain excellent working relationships with physicians and others in the medical industry that enable us to gain a detailed understanding of therapeutic and diagnostic developments, trends, and emerging opportunities and respond quickly to the changing needs of physicians and patients. We attempt to enhance our presence in the medical community through active participation in medical meetings and by conducting comprehensive training and educational activities. We believe that these activities contribute to physician expertise.

In keeping with the increased emphasis on cost-effectiveness in health care delivery, the current trend among hospitals and other customers of medical device manufacturers is to consolidate into larger purchasing groups to enhance purchasing power. As a result, transactions with customers have become increasingly significant and more complex. This enhanced purchasing power may also lead to pressure on pricing and increased use of preferred vendors. Our customer base continues to evolve to reflect such economic changes across the geographic markets we serve. We are not dependent on any single customer for more than 10 percent of our total net sales.










MDT's vs. Customers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Medtronic Plc 111,410.02 32,319.00 4,234.00 95,000
Quest Diagnostics Inc 14,610.36 9,252.00 908.00 49,000
Neogenomics Inc 1,846.07 591.60 -87.97 2,000
Cvs Health Corporation 100,037.72 357,776.00 8,368.00 300,000
Davita Inc 12,770.10 12,140.15 956.98 69,000
Fresenius Medical Care Ag 5,586.59 21,788.05 820.35 1,254
Heartland Media Acquisition Corp 202.86 0.00 4.01 0
Rite Aid Corp 35.86 23,475.49 -1,635.20 50,000
Tenet Healthcare Corp 10,741.19 20,548.00 1,311.00 108,000
SUBTOTAL 145,830.75 445,571.29 10,645.17 579,254


Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com